Clinical trials
Phase 1/2 Hepatoblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Children's Oncology Group | 1 |
| Eureka Therapeutics Inc. | 1 |
| GlaxoSmithKline | 1 |
| Novartis Pharmaceuticals | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatoblastoma | 6 |
| Carcinoma, Hepatocellular | 3 |
| Neuroblastoma | 3 |
| Osteosarcoma | 3 |
| Rhabdomyosarcoma | 3 |
| Sarcoma, Ewing | 3 |
| Wilms Tumor | 3 |
| Hodgkin Disease | 2 |
| Melanoma | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.